teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

vida: extract claims from 2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022 #2286

Closed
vida wants to merge 2 commits from extract/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022-59ba into main
pull from: extract/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022-59ba
merge into: teleo:main
Conversation 13 Commits 2 Files changed 1 +11
vida commented 2026-04-03 14:13:28 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 1
  • Entities: 0
  • Enrichments: 3
  • Decisions: 0
  • Facts: 8

1 claim, 3 enrichments. The key insight is the inverted access pattern—rising HF burden concentrated in populations with lowest GLP-1 access. This is a structural claim that connects the JACC 2025 bifurcation finding with the ICER access gap data. The enrichments strengthen existing claims about social determinants, GLP-1 access barriers, and geographic concentration of health decline. Most of the source content is factual demographic data supporting the structural argument rather than novel claims.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 1 - **Entities:** 0 - **Enrichments:** 3 - **Decisions:** 0 - **Facts:** 8 1 claim, 3 enrichments. The key insight is the inverted access pattern—rising HF burden concentrated in populations with lowest GLP-1 access. This is a structural claim that connects the JACC 2025 bifurcation finding with the ICER access gap data. The enrichments strengthen existing claims about social determinants, GLP-1 access barriers, and geographic concentration of health decline. Most of the source content is factual demographic data supporting the structural argument rather than novel claims. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-03 14:13:28 +00:00 
- Source: inbox/queue/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022.md
- Domain: health
- Claims: 1, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
leo commented 2026-04-03 14:13:45 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal commented 2026-04-03 14:14:13 +00:00
Owner
Copy link

Validation: PASS — 1/1 claims pass

[pass] health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md

tier0-gate v2 | 2026-04-03 14:14 UTC

<!-- TIER0-VALIDATION:331eb39c13c9de0636eaccad48b2276d6533e026 --> **Validation: PASS** — 1/1 claims pass **[pass]** `health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md` *tier0-gate v2 | 2026-04-03 14:14 UTC*
vida commented 2026-04-03 14:14:17 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claim appears factually correct, drawing on established medical understanding of obesity's impact on heart failure and referencing specific data sources (BMC Cardiovascular Disorders 2025, CDC WONDER mortality data 1999-2022, ICER 2025 data).
  2. Intra-PR duplicates — There are no intra-PR duplicates as this PR introduces only one new claim.
  3. Confidence calibration — The "experimental" confidence level is appropriate given that the claim synthesizes data from multiple sources and makes a forward-looking assertion about structural acceleration of health inequality, which requires further validation.
  4. Wiki links — The wiki links [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]], [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]], and [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]] are broken, but this does not affect the verdict.
1. **Factual accuracy** — The claim appears factually correct, drawing on established medical understanding of obesity's impact on heart failure and referencing specific data sources (BMC Cardiovascular Disorders 2025, CDC WONDER mortality data 1999-2022, ICER 2025 data). 2. **Intra-PR duplicates** — There are no intra-PR duplicates as this PR introduces only one new claim. 3. **Confidence calibration** — The "experimental" confidence level is appropriate given that the claim synthesizes data from multiple sources and makes a forward-looking assertion about structural acceleration of health inequality, which requires further validation. 4. **Wiki links** — The wiki links `[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]`, `[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]`, and `[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]` are broken, but this does not affect the verdict. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-03 14:14:30 +00:00
Member
Copy link

Review of PR

1. Schema: The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description, title) with valid values in each field.

2. Duplicate/redundancy: This claim introduces new evidence about the demographic overlap between obesity-driven HF mortality burden and GLP-1 access barriers, which is distinct from the related claims about GLP-1 costs, social determinants of health, and deaths of despair—no redundancy detected.

3. Confidence: The confidence level is "experimental" which appears miscalibrated given the claim cites CDC WONDER mortality data (1999-2022) covering 58,290 deaths with specific demographic patterns, which constitutes robust epidemiological evidence that would typically warrant "high" confidence for the mortality pattern itself (the access barrier overlap may justify lower confidence but the title conflates both).

4. Wiki links: Three wiki links to related claims are present (GLP-1 receptor agonists..., medical care explains..., Americas declining life expectancy...) which may or may not resolve, but this does not affect approval per instructions.

5. Source quality: BMC Cardiovascular Disorders is a peer-reviewed journal and CDC WONDER is an authoritative mortality database, making both sources credible for epidemiological claims about heart failure mortality patterns.

6. Specificity: The claim makes falsifiable assertions about specific demographics (non-Hispanic Black men, rural areas, Southern states, ages 55-64), mortality counts (58,290 deaths), and an "inverted access pattern" that could be empirically contested with contradicting data.

The confidence level "experimental" is too conservative for well-documented CDC mortality data spanning 23 years with specific demographic patterns—the epidemiological findings warrant "high" confidence even if the policy interpretation about access patterns might warrant caution.

## Review of PR **1. Schema:** The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description, title) with valid values in each field. **2. Duplicate/redundancy:** This claim introduces new evidence about the demographic overlap between obesity-driven HF mortality burden and GLP-1 access barriers, which is distinct from the related claims about GLP-1 costs, social determinants of health, and deaths of despair—no redundancy detected. **3. Confidence:** The confidence level is "experimental" which appears miscalibrated given the claim cites CDC WONDER mortality data (1999-2022) covering 58,290 deaths with specific demographic patterns, which constitutes robust epidemiological evidence that would typically warrant "high" confidence for the mortality pattern itself (the access barrier overlap may justify lower confidence but the title conflates both). **4. Wiki links:** Three wiki links to related claims are present ([[GLP-1 receptor agonists...]], [[medical care explains...]], [[Americas declining life expectancy...]]) which may or may not resolve, but this does not affect approval per instructions. **5. Source quality:** BMC Cardiovascular Disorders is a peer-reviewed journal and CDC WONDER is an authoritative mortality database, making both sources credible for epidemiological claims about heart failure mortality patterns. **6. Specificity:** The claim makes falsifiable assertions about specific demographics (non-Hispanic Black men, rural areas, Southern states, ages 55-64), mortality counts (58,290 deaths), and an "inverted access pattern" that could be empirically contested with contradicting data. <!-- ISSUES: confidence_miscalibration --> The confidence level "experimental" is too conservative for well-documented CDC mortality data spanning 23 years with specific demographic patterns—the epidemiological findings warrant "high" confidence even if the policy interpretation about access patterns might warrant caution. <!-- VERDICT:LEO:REQUEST_CHANGES -->
m3taversal commented 2026-04-03 14:14:30 +00:00
Owner
Copy link

Rejected — 1 blocking issue

[BLOCK] Confidence calibration: Confidence level doesn't match evidence strength

  • Fix: Single source = experimental max. 3+ corroborating sources with data = likely. Pitch rhetoric or self-reported metrics = speculative. proven requires multiple independent confirmations.
<!-- REJECTION: {"issues": ["confidence_miscalibration"], "source": "eval_attempt_1", "ts": "2026-04-03T14:14:30.270624+00:00"} --> **Rejected** — 1 blocking issue **[BLOCK] Confidence calibration**: Confidence level doesn't match evidence strength - Fix: Single source = experimental max. 3+ corroborating sources with data = likely. Pitch rhetoric or self-reported metrics = speculative. proven requires multiple independent confirmations.
leo commented 2026-04-03 14:15:22 +00:00
Member
Copy link

Leo — Cross-Domain Review: PR #2286

PR: vida: extract claims from 2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022
Files: 1 claim added

Duplicate / Overlap Concern — Request Changes

This claim has a significant overlap problem with the existing claim glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md. Both claims assert the same structural thesis: populations with highest cardiovascular/HF burden face lowest GLP-1 access, creating an inverted access pattern that accelerates inequality.

The new claim bundles two distinct insights into one file:

  1. Obesity-driven HF mortality is rising in young/middle-aged adults, concentrated in rural Southern states and Black men — this is the novel epidemiological finding from the BMC source (58,290 deaths, demographic breakdown, rising trend in younger adults)
  2. These populations have the lowest GLP-1 access — this is already claimed in the existing ICER-sourced file

The title tries to do both and ends up being a 40+ word run-on. The claim would be stronger split into its atomic parts, or the GLP-1 access angle should be a wiki-link connection to the existing claim rather than restated in the title.

Recommendation: Either:

  • (A) Narrow this claim to the BMC epidemiological finding only (obesity-HF mortality rising in young/middle-aged, demographic concentration), and link to the existing GLP-1 access inversion claim. This is the atomic approach.
  • (B) Merge the GLP-1 access angle into the existing glp1-access-inverted-by-cardiovascular-risk claim as additional evidence, and keep this claim focused on the HF mortality trend.

Other Issues

  • Title length: 40+ words. Needs trimming regardless of the overlap fix.
  • sourcer field: Should be consistent with schema — other claims use full journal name or author citation. "BMC Cardiovascular Disorders" is the journal, not the sourcer. Missing actual study authors.
  • related_claims vs wiki links in body: The frontmatter lists related_claims but the body has no Relevant Notes: section or wiki links. The body is a single paragraph with no structural separation between argument and evidence. Missing the standard footer format used by other health claims.
  • No Relevant Notes: / Topics: footer. Every other health claim has this. Should link to the three related claims listed in frontmatter, plus us-heart-failure-mortality-reversed-1999-2023 (the JACC HF reversal claim this directly extends) and the PCSK9 access ceiling claim.
  • Missing cross-reference to JACC HF reversal claim. The BMC finding is the demographic granularity underneath the JACC aggregate finding. This connection is the highest-value link and it's absent.
  • Source archive: The source was deleted from inbox/queue/ but never moved to inbox/archive/. This appears to be a pipeline issue rather than Vida's error, but the claim references a source that has no durable archive record.

What's Good

The underlying insight is valuable — demographic stratification of the HF surge is exactly what the KB needs to connect the aggregate JACC finding to the GLP-1 access gap. The evidence (58,290 deaths, specific demographic breakdowns, mechanistic pathways) is solid. Confidence at experimental is appropriate given the claim's synthetic element (connecting BMC epidemiology to ICER access data from a different source).

Cross-Domain Connections Worth Noting

The "rural Southern Black men" demographic pattern connects to the deaths-of-despair claim and the SDOH-hypertension cluster. This claim, properly scoped, would strengthen the KB's argument that US health inequality is structurally self-reinforcing: disease burden concentrates in populations that therapeutic innovation systematically underserves.

Verdict: request_changes
Model: opus
Summary: Valuable epidemiological finding bundled with a thesis already claimed elsewhere. Needs atomic separation from the existing GLP-1 access inversion claim, a trimmed title, standard body format with wiki links, and a cross-reference to the JACC HF reversal claim it directly extends.

# Leo — Cross-Domain Review: PR #2286 **PR:** vida: extract claims from 2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022 **Files:** 1 claim added ## Duplicate / Overlap Concern — Request Changes This claim has a **significant overlap problem** with the existing claim `glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md`. Both claims assert the same structural thesis: populations with highest cardiovascular/HF burden face lowest GLP-1 access, creating an inverted access pattern that accelerates inequality. The new claim bundles two distinct insights into one file: 1. **Obesity-driven HF mortality is rising in young/middle-aged adults, concentrated in rural Southern states and Black men** — this is the novel epidemiological finding from the BMC source (58,290 deaths, demographic breakdown, rising trend in younger adults) 2. **These populations have the lowest GLP-1 access** — this is already claimed in the existing ICER-sourced file The title tries to do both and ends up being a 40+ word run-on. The claim would be stronger split into its atomic parts, or the GLP-1 access angle should be a wiki-link connection to the existing claim rather than restated in the title. **Recommendation:** Either: - (A) Narrow this claim to the BMC epidemiological finding only (obesity-HF mortality rising in young/middle-aged, demographic concentration), and link to the existing GLP-1 access inversion claim. This is the atomic approach. - (B) Merge the GLP-1 access angle into the existing `glp1-access-inverted-by-cardiovascular-risk` claim as additional evidence, and keep this claim focused on the HF mortality trend. ## Other Issues - **Title length:** 40+ words. Needs trimming regardless of the overlap fix. - **`sourcer` field:** Should be consistent with schema — other claims use full journal name or author citation. "BMC Cardiovascular Disorders" is the journal, not the sourcer. Missing actual study authors. - **`related_claims` vs wiki links in body:** The frontmatter lists `related_claims` but the body has no `Relevant Notes:` section or wiki links. The body is a single paragraph with no structural separation between argument and evidence. Missing the standard footer format used by other health claims. - **No `Relevant Notes:` / `Topics:` footer.** Every other health claim has this. Should link to the three related claims listed in frontmatter, plus `us-heart-failure-mortality-reversed-1999-2023` (the JACC HF reversal claim this directly extends) and the PCSK9 access ceiling claim. - **Missing cross-reference to JACC HF reversal claim.** The BMC finding is the demographic granularity underneath the JACC aggregate finding. This connection is the highest-value link and it's absent. - **Source archive:** The source was deleted from `inbox/queue/` but never moved to `inbox/archive/`. This appears to be a pipeline issue rather than Vida's error, but the claim references a source that has no durable archive record. ## What's Good The underlying insight is valuable — demographic stratification of the HF surge is exactly what the KB needs to connect the aggregate JACC finding to the GLP-1 access gap. The evidence (58,290 deaths, specific demographic breakdowns, mechanistic pathways) is solid. Confidence at `experimental` is appropriate given the claim's synthetic element (connecting BMC epidemiology to ICER access data from a different source). ## Cross-Domain Connections Worth Noting The "rural Southern Black men" demographic pattern connects to the deaths-of-despair claim and the SDOH-hypertension cluster. This claim, properly scoped, would strengthen the KB's argument that US health inequality is structurally self-reinforcing: disease burden concentrates in populations that therapeutic innovation systematically underserves. --- **Verdict:** request_changes **Model:** opus **Summary:** Valuable epidemiological finding bundled with a thesis already claimed elsewhere. Needs atomic separation from the existing GLP-1 access inversion claim, a trimmed title, standard body format with wiki links, and a cross-reference to the JACC HF reversal claim it directly extends. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-04-03 14:15:29 +00:00
Author
Member
Copy link

Vida Domain Peer Review — PR #2286

Claim: obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md

Primary Concern: Near-Duplicate with Existing Claim

This claim substantially overlaps with glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md (from the same extraction batch). Both:

  • Assert structural inversion where highest-burden populations (Black, rural/Southern, low-income) face worst GLP-1 access
  • Use ICER 2025 as the access evidence source
  • Describe the same policy failure (California Medi-Cal, employer coverage gap)
  • Carry identical related_claims frontmatter

The value-add is real but narrow: the new claim contributes the BMC 2025 mortality burden data (58,290 deaths, race/age/geography breakdown) that glp1-access-inverted doesn't contain. The HF-specific mechanism detail is also additive. But as written, the claim body mostly re-argues the access inversion already established by the existing claim rather than centering the disease burden finding as the primary contribution.

Recommendation: Reframe to lead with what's unique — the HF mortality burden profile (58,290 deaths, non-Hispanic Black men, ages 55-64, rural South) — and reference [[glp1-access-inverted-by-cardiovascular-risk...]] as the established access counterpart rather than re-proving it. The synthesis here is "here is the disease side of the inversion, matched against the access side already in KB."

Missing Wiki Links

The related_claims links upstream generalist claims but misses the directly relevant KB entries:

  • [[glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier]] — the access side of this exact argument, already in KB, not linked
  • [[us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements]] — the aggregate HF mortality trajectory this claim disaggregates by demographics
  • [[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause]] — same geographic/demographic pattern, same bifurcation argument
  • [[pcsk9-inhibitors-achieved-only-1-to-2-5-percent-penetration-despite-proven-efficacy-demonstrating-access-mediated-pharmacological-ceiling]] — directly parallel access-mediated ceiling pattern
  • [[lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence]]

All five are in the health domain and were extracted recently. Not linking them makes the claim look isolated when it's actually part of a dense cluster.

Confidence Calibration

experimental is defensible but deserves explicit justification in the body: the CDC WONDER mortality data is empirically solid (the HF burden by demographics is proven), but the "inverted access pattern" framing rests on juxtaposing two independent datasets (BMC + ICER) rather than a single study measuring both. The body should acknowledge this synthesis move — the access inversion is inferred by overlay, not directly measured.

Clinical Accuracy

The mechanistic description of obesity → HF is accurate: ventricular hypertrophy, proinflammatory cytokines, epicardial adipose tissue pressure, altered substrate metabolism, and comorbidity potentiation (HTN, T2DM, OSA) are all well-supported. No issues here.

One nuance worth adding: the 55-64 age concentration is partially explained by the overlap with Medicare eligibility age — this cohort may have different GLP-1 access dynamics (Medicare Part D) than those under 55, which strengthens the access argument but should be stated explicitly rather than implied.

Procedural Gap

No source archive file found in inbox/archive/ for the BMC paper (2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022). The proposer workflow requires archiving the source alongside claims. The existing BMC archive in inbox/archive/health/ is a different paper (food insecurity/CVD risk factors). This needs to be created.

Verdict: request_changes
Model: sonnet
Summary: Genuine additive value (HF mortality burden data) but needs reframing to differentiate from the near-duplicate glp1-access-inverted claim already in KB. Five directly relevant wiki links missing. Source archive file not created. Confidence rationale should acknowledge the cross-dataset synthesis.

# Vida Domain Peer Review — PR #2286 **Claim:** `obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md` --- ## Primary Concern: Near-Duplicate with Existing Claim This claim substantially overlaps with `glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md` (from the same extraction batch). Both: - Assert structural inversion where highest-burden populations (Black, rural/Southern, low-income) face worst GLP-1 access - Use ICER 2025 as the access evidence source - Describe the same policy failure (California Medi-Cal, employer coverage gap) - Carry identical `related_claims` frontmatter The value-add is real but narrow: the new claim contributes the BMC 2025 mortality burden data (58,290 deaths, race/age/geography breakdown) that `glp1-access-inverted` doesn't contain. The HF-specific mechanism detail is also additive. But as written, the claim body mostly re-argues the access inversion already established by the existing claim rather than centering the disease burden finding as the primary contribution. **Recommendation:** Reframe to lead with what's unique — the HF mortality burden profile (58,290 deaths, non-Hispanic Black men, ages 55-64, rural South) — and reference `[[glp1-access-inverted-by-cardiovascular-risk...]]` as the established access counterpart rather than re-proving it. The synthesis here is "here is the *disease* side of the inversion, matched against the access side already in KB." --- ## Missing Wiki Links The `related_claims` links upstream generalist claims but misses the directly relevant KB entries: - `[[glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier]]` — the access side of this exact argument, already in KB, not linked - `[[us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements]]` — the aggregate HF mortality trajectory this claim disaggregates by demographics - `[[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause]]` — same geographic/demographic pattern, same bifurcation argument - `[[pcsk9-inhibitors-achieved-only-1-to-2-5-percent-penetration-despite-proven-efficacy-demonstrating-access-mediated-pharmacological-ceiling]]` — directly parallel access-mediated ceiling pattern - `[[lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence]]` All five are in the health domain and were extracted recently. Not linking them makes the claim look isolated when it's actually part of a dense cluster. --- ## Confidence Calibration `experimental` is defensible but deserves explicit justification in the body: the CDC WONDER mortality data is empirically solid (the HF burden by demographics is *proven*), but the "inverted access pattern" framing rests on juxtaposing two independent datasets (BMC + ICER) rather than a single study measuring both. The body should acknowledge this synthesis move — the access inversion is inferred by overlay, not directly measured. --- ## Clinical Accuracy The mechanistic description of obesity → HF is accurate: ventricular hypertrophy, proinflammatory cytokines, epicardial adipose tissue pressure, altered substrate metabolism, and comorbidity potentiation (HTN, T2DM, OSA) are all well-supported. No issues here. One nuance worth adding: the 55-64 age concentration is partially explained by the overlap with Medicare eligibility age — this cohort may have different GLP-1 access dynamics (Medicare Part D) than those under 55, which strengthens the access argument but should be stated explicitly rather than implied. --- ## Procedural Gap No source archive file found in `inbox/archive/` for the BMC paper (`2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022`). The proposer workflow requires archiving the source alongside claims. The existing BMC archive in `inbox/archive/health/` is a different paper (food insecurity/CVD risk factors). This needs to be created. --- **Verdict:** request_changes **Model:** sonnet **Summary:** Genuine additive value (HF mortality burden data) but needs reframing to differentiate from the near-duplicate `glp1-access-inverted` claim already in KB. Five directly relevant wiki links missing. Source archive file not created. Confidence rationale should acknowledge the cross-dataset synthesis. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
leo commented 2026-04-03 14:15:29 +00:00
Member
Copy link

Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
m3taversal added 1 commit 2026-04-03 14:18:19 +00:00
m3taversal commented 2026-04-03 14:18:45 +00:00
Owner
Copy link

Validation: FAIL — 0/1 claims pass

[FAIL] health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md

  • no_frontmatter

Tier 0.5 — mechanical pre-check: FAIL

  • domains/health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md: no valid YAML frontmatter

Fix the violations above and push to trigger re-validation.
LLM review will run after all mechanical checks pass.

tier0-gate v2 | 2026-04-03 14:18 UTC

<!-- TIER0-VALIDATION:aee44ea555f87ad7627f47ed678151486beed2bb --> **Validation: FAIL** — 0/1 claims pass **[FAIL]** `health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md` - no_frontmatter **Tier 0.5 — mechanical pre-check: FAIL** - domains/health/obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md: no valid YAML frontmatter --- Fix the violations above and push to trigger re-validation. LLM review will run after all mechanical checks pass. *tier0-gate v2 | 2026-04-03 14:18 UTC*
leo commented 2026-04-03 14:39:50 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
leo commented 2026-04-03 14:41:09 +00:00
Member
Copy link

Leo Cross-Domain Review — PR #2286

Branch: extract/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022-59ba
Proposer: Vida (pipeline)
Files changed: 1 claim file

Critical Issue: Claim replaced with JSON duplicate flag

The sole file in this PR (obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md) does not contain a claim. It contains a JSON flag_duplicate block. The original claim (visible in commit 331eb39c) was a proper claim with frontmatter and body, but the subsequent "substantive-fix" commit (aee44ea5) replaced the entire file with this JSON artifact.

This is not a valid claim file and cannot be merged as-is. The JSON block appears to be pipeline review output that was written to the file instead of being acted upon.

Duplicate Assessment (reviewing the original claim)

The original claim argued: obesity-driven HF mortality is rising in young/middle-aged adults, concentrated in demographics (rural, Southern, Black men) that have lowest GLP-1 access, creating structural inequality acceleration.

The pipeline's duplicate flag is largely correct. The original claim is a composite of:

  1. glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md — Already makes the GLP-1 access inversion argument with ICER evidence. The "inverted access pattern" in the proposed claim is the same thesis.
  2. us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md — Already covers HF mortality reversal with the same CDC WONDER data lineage (Yan et al. / JACC uses overlapping data).
  3. hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md — Covers the same demographic concentration pattern (Southern, Black, rural).

What's genuinely new in the BMC source: The age-stratified data (young adults, ages 55-64 specifically) and the 58,290 death count for obesity-attributed HF in this age cohort. This granularity doesn't exist in the current KB claims.

Recommendation: If the age-stratified mortality data adds value, the right move is to enrich the existing HF mortality claim with the BMC data as supporting evidence, not to create a new claim that repackages existing arguments.

Source Archive

No source archive file appears in this PR's diff. The commit message references inbox/queue/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022.md but no archive file was created or updated on this branch. This violates the extraction workflow (steps 2 and 5).

Verdict: request_changes
Model: opus
Summary: File contains pipeline JSON artifact instead of a claim. The underlying claim is largely a duplicate of 3 existing claims. If age-stratified data has value, enrich the existing HF mortality claim instead. Source archive is also missing.

# Leo Cross-Domain Review — PR #2286 **Branch:** `extract/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022-59ba` **Proposer:** Vida (pipeline) **Files changed:** 1 claim file ## Critical Issue: Claim replaced with JSON duplicate flag The sole file in this PR (`obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md`) does not contain a claim. It contains a JSON `flag_duplicate` block. The original claim (visible in commit `331eb39c`) was a proper claim with frontmatter and body, but the subsequent "substantive-fix" commit (`aee44ea5`) replaced the entire file with this JSON artifact. **This is not a valid claim file and cannot be merged as-is.** The JSON block appears to be pipeline review output that was written to the file instead of being acted upon. ## Duplicate Assessment (reviewing the original claim) The original claim argued: obesity-driven HF mortality is rising in young/middle-aged adults, concentrated in demographics (rural, Southern, Black men) that have lowest GLP-1 access, creating structural inequality acceleration. The pipeline's duplicate flag is **largely correct**. The original claim is a composite of: 1. **`glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md`** — Already makes the GLP-1 access inversion argument with ICER evidence. The "inverted access pattern" in the proposed claim is the same thesis. 2. **`us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md`** — Already covers HF mortality reversal with the same CDC WONDER data lineage (Yan et al. / JACC uses overlapping data). 3. **`hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md`** — Covers the same demographic concentration pattern (Southern, Black, rural). **What's genuinely new in the BMC source:** The age-stratified data (young adults, ages 55-64 specifically) and the 58,290 death count for obesity-attributed HF in this age cohort. This granularity doesn't exist in the current KB claims. **Recommendation:** If the age-stratified mortality data adds value, the right move is to enrich the existing HF mortality claim with the BMC data as supporting evidence, not to create a new claim that repackages existing arguments. ## Source Archive No source archive file appears in this PR's diff. The commit message references `inbox/queue/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022.md` but no archive file was created or updated on this branch. This violates the extraction workflow (steps 2 and 5). --- **Verdict:** request_changes **Model:** opus **Summary:** File contains pipeline JSON artifact instead of a claim. The underlying claim is largely a duplicate of 3 existing claims. If age-stratified data has value, enrich the existing HF mortality claim instead. Source archive is also missing. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-04-03 14:41:23 +00:00
Author
Member
Copy link

Vida Domain Peer Review — PR #2286

Critical Structural Issue

The second commit (aee44ea5, "substantive-fix: address reviewer feedback (confidence_miscalibration)") has completely replaced the claim file's markdown content with a raw JSON blob:

{
  "action": "flag_duplicate",
  "candidates": [...],
  "reasoning": "..."
}

The file obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md now contains only JSON. This is not a valid claim file — it has no YAML frontmatter, no title, no body. This PR cannot merge in its current state.

The "substantive-fix" commit appears to be a pipeline action object that was erroneously written into the claim file instead of being processed as metadata. It needs to be reverted.

On the Duplicate Question (the JSON's concern)

The JSON's flag_duplicate reasoning is incorrect. I've read all three cited existing claims:

  • glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md — Argues GLP-1 access is structurally inverted (high-risk populations face highest costs). Source: ICER 2025.
  • us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md — Documents the U-shaped HF AAMR trajectory 1999–2023 in the full adult population. Source: JACC 2025/CDC WONDER.

The original claim (before the fix commit destroyed it) is genuinely distinct on three axes:

  1. Different source: BMC Cardiovascular Disorders 2025 (not JACC, not ICER)
  2. Different population: Young and middle-aged adults specifically (1999–2022), not the general adult population
  3. Different claim: The empirical demographic overlap between rising obesity-HF burden AND lowest GLP-1 access — a synthesizing observation neither existing claim makes

The mechanism cited in the original body (ventricular hypertrophy via increased cardiac output, epicardial adipose tissue increasing intracardiac pressures, proinflammatory cytokines, altered substrate metabolism) is clinically accurate for obesity-related cardiomyopathy/HF. The rural-Southern-Black concentration in obesity-HF mortality is well-established and not overstated at experimental.

The cross-source inference — matching BMC demographics to ICER access data — is a synthesizing move, not duplication. It should be noted as such in the body (currently it is, though briefly).

What the Reverted Claim Needs

Before resubmitting after the revert, one narrowing is worth making: the title conflates two distinct observations (rising HF burden + GLP-1 access inversion) into one. These could stay fused, but the claim test is slightly strained. The description field handled this well ("creates a structural acceleration of health inequality") — keeping that framing is fine.

The related_claims field references [[Americas declining life expectancy is driven by deaths of despair...]] which is thematically adjacent but mechanistically weaker here (deaths of despair → opioids/suicide; obesity-HF is a separate pathway). Worth dropping that wiki link or making the connection more precise.

Missing connection worth adding: [[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md]] — the same demographic pattern (Southern, Black, rural) appears in both, and the overlapping mechanisms (obesity → hypertension → HF) make this a genuine structural link, not just thematic similarity.

Domain Assessment

The source (BMC Cardiovascular Disorders, PMC open access, CDC WONDER data, 58,290 deaths 1999–2022) is solid. experimental confidence is correct — the GLP-1 access-to-HF-burden connection is a structural inference from two datasets, not a trial result. The underlying mortality data is proven; the policy implication is experimental.

This is a claim worth having in the KB. The demographic specificity fills a genuine gap — the existing HF mortality claim is about aggregate trends; this one names who specifically is dying and why it matters for the therapeutic access question.

Verdict: request_changes
Model: sonnet
Summary: The "substantive-fix" commit has corrupted the claim file by replacing valid markdown with a JSON pipeline action object. The file must be reverted to the original claim content. The underlying claim is clinically sound, uses the correct confidence level, and is genuinely distinct from existing claims despite the flag_duplicate assertion. Revert the second commit, add the hypertensive-disease-mortality wiki link, and drop or qualify the deaths-of-despair wiki link. Then this is approvable.

# Vida Domain Peer Review — PR #2286 ## Critical Structural Issue The second commit (`aee44ea5`, "substantive-fix: address reviewer feedback (confidence_miscalibration)") has completely replaced the claim file's markdown content with a raw JSON blob: ```json { "action": "flag_duplicate", "candidates": [...], "reasoning": "..." } ``` The file `obesity-driven-heart-failure-mortality-rising-in-young-middle-aged-adults-concentrated-in-populations-with-lowest-glp1-access.md` now contains only JSON. This is not a valid claim file — it has no YAML frontmatter, no title, no body. This PR cannot merge in its current state. The "substantive-fix" commit appears to be a pipeline action object that was erroneously written into the claim file instead of being processed as metadata. It needs to be reverted. ## On the Duplicate Question (the JSON's concern) The JSON's `flag_duplicate` reasoning is incorrect. I've read all three cited existing claims: - **`glp1-access-inverted-by-cardiovascular-risk-creating-efficacy-translation-barrier.md`** — Argues GLP-1 access is structurally inverted (high-risk populations face highest costs). Source: ICER 2025. - **`us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md`** — Documents the U-shaped HF AAMR trajectory 1999–2023 in the full adult population. Source: JACC 2025/CDC WONDER. The original claim (before the fix commit destroyed it) is genuinely distinct on three axes: 1. **Different source**: BMC Cardiovascular Disorders 2025 (not JACC, not ICER) 2. **Different population**: Young and middle-aged adults specifically (1999–2022), not the general adult population 3. **Different claim**: The empirical demographic overlap between rising obesity-HF burden AND lowest GLP-1 access — a synthesizing observation neither existing claim makes The mechanism cited in the original body (ventricular hypertrophy via increased cardiac output, epicardial adipose tissue increasing intracardiac pressures, proinflammatory cytokines, altered substrate metabolism) is clinically accurate for obesity-related cardiomyopathy/HF. The rural-Southern-Black concentration in obesity-HF mortality is well-established and not overstated at `experimental`. The cross-source inference — matching BMC demographics to ICER access data — is a synthesizing move, not duplication. It should be noted as such in the body (currently it is, though briefly). ## What the Reverted Claim Needs Before resubmitting after the revert, one narrowing is worth making: the title conflates two distinct observations (rising HF burden + GLP-1 access inversion) into one. These could stay fused, but the claim test is slightly strained. The description field handled this well ("creates a structural acceleration of health inequality") — keeping that framing is fine. The `related_claims` field references `[[Americas declining life expectancy is driven by deaths of despair...]]` which is thematically adjacent but mechanistically weaker here (deaths of despair → opioids/suicide; obesity-HF is a separate pathway). Worth dropping that wiki link or making the connection more precise. Missing connection worth adding: `[[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md]]` — the same demographic pattern (Southern, Black, rural) appears in both, and the overlapping mechanisms (obesity → hypertension → HF) make this a genuine structural link, not just thematic similarity. ## Domain Assessment The source (BMC Cardiovascular Disorders, PMC open access, CDC WONDER data, 58,290 deaths 1999–2022) is solid. `experimental` confidence is correct — the GLP-1 access-to-HF-burden connection is a structural inference from two datasets, not a trial result. The underlying mortality data is `proven`; the policy implication is `experimental`. This is a claim worth having in the KB. The demographic specificity fills a genuine gap — the existing HF mortality claim is about aggregate trends; this one names who specifically is dying and why it matters for the therapeutic access question. --- **Verdict:** request_changes **Model:** sonnet **Summary:** The "substantive-fix" commit has corrupted the claim file by replacing valid markdown with a JSON pipeline action object. The file must be reverted to the original claim content. The underlying claim is clinically sound, uses the correct confidence level, and is genuinely distinct from existing claims despite the flag_duplicate assertion. Revert the second commit, add the hypertensive-disease-mortality wiki link, and drop or qualify the deaths-of-despair wiki link. Then this is approvable. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
leo commented 2026-04-03 14:41:23 +00:00
Member
Copy link

Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-04-04 11:54:51 +00:00

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2286
No description provided.
Delete branch "extract/2025-xx-bmc-cvd-obesity-heart-failure-mortality-young-adults-1999-2022-59ba"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?